{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:12:33Z","timestamp":1787026353275,"version":"build-2736575974"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T00:00:00Z","timestamp":1642636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017515","name":"Heidelberger Stiftung Chirurgie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017515","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>\n                    Both aortic aneurysm and dissection are life threatening pathologies. In the lack of a conservative medical treatment, the only therapy consists of modifying cardiovascular risk factors and either surgical or endovascular treatment. Like many other cardiovascular diseases, in particular atherosclerosis, aortic aneurysm and dissection have a strong inflammatory phenotype. Inflammasomes are part of the innate immune system. Upon stimulation they form multi protein complexes resulting mainly in activation of interleukin-1\u03b2 and other cytokines. Considering the gathering evidence, that inflammasomes are decisively involved in the emergence and progression of aortic diseases, inflammasome targeted therapy provides a promising new treatment approach. A systematic review following the PRISMA guidelines on the current preclinical data regarding the potential role of inflammasome targeted drug therapy as novel treatment option for aortic aneurysms and dissections was performed. Included were all rodent models of aortic disease (aortic aneurysm and dissection) evaluating a drug therapy with direct or indirect inhibition of inflammasomes and a suitable control group with the use of the same aortic model without the inflammasome targeted therapy. Primary and secondary outcomes were incidence of aortic disease, aortic rupture, aortic related death, and the maximum aortic diameter. The literature search of MEDLINE (\n                    <jats:italic>via<\/jats:italic>\n                    PubMed), the Web of Science, EMBASE and the Cochrane Central Registry of Registered Trials (CENTRAL) resulted in 8,137 hits. Of these, four studies met the inclusion criteria and were therefore eligible for data analysis. In all of them, targeting of the NOD-, LRR- and pyrin domain-containing protein 3 (NLRP3) inflammasome effectively reduced the incidence of aortic disease and aortic rupture, and additionally reduced destruction of the aortic wall. Treatment strategies aiming at other inflammasomes could not be identified. In conclusion, inflammasome targeted therapies, more precisely targeting the NLRP3 inflammasome, have shown promising results in rodent models and deserve further investigation in preclinical research to potentially translate them into clinical research for the treatment of human patients with aortic disease. Regarding other inflammasomes, more preclinical research is needed to investigate their role in the pathophysiology of aortic disease.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Protocol Registration:<\/jats:bold>\n                    PROSPERO 2021 CRD42021279893,\n                    <jats:ext-link>https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?ID=CRD42021279893<\/jats:ext-link>\n                  <\/jats:p>","DOI":"10.3389\/fcvm.2021.805150","type":"journal-article","created":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T01:45:12Z","timestamp":1642643112000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Inflammasome Targeted Therapy as Novel Treatment Option for Aortic Aneurysms and Dissections: A Systematic Review of the Preclinical Evidence"],"prefix":"10.3389","volume":"8","author":[{"given":"Markus","family":"Wortmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Klotz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Kalkum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Dihlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dittmar","family":"B\u00f6ckler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas S.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.5603\/KP.2014.0225","volume":"72","author":"Erbel","year":"2014","journal-title":"Kardiol Pol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.3390\/cells10092433","article-title":"Inflammasomes in the pathophysiology of aortic disease","volume":"10","author":"Wortmann","year":"2021","journal-title":"Cells."},{"key":"B3","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/S0741-5214(95)70227-X","article-title":"Ruptured thoracic aortic aneurysms: a study of incidence and mortality rates","volume":"21","author":"Johansson","year":"1995","journal-title":"J Vasc Surg."},{"key":"B4","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3238\/arztebl.2017.0391","article-title":"Incidence, treatment and mortality in patients with abdominal aortic aneurysms","volume":"114","author":"K\u00fchnl","year":"2017","journal-title":"Dtsch Arztebl Int."},{"key":"B5","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1001\/jama.283.7.897","article-title":"The international registry of acute aortic dissection (IRAD): new insights into an old disease","volume":"283","author":"Hagan","year":"2000","journal-title":"JAMA."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1093\/ejcts\/ezw235","article-title":"The incidence and mortality of acute thoracic aortic dissection: results from a whole nation study","volume":"50","author":"Melvinsdottir","year":"2016","journal-title":"Eur J Cardiothorac Surg."},{"key":"B7","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/S0140-6736(14)61005-9","article-title":"Management of acute aortic dissection","volume":"385","author":"Nienaber","year":"2015","journal-title":"Lancet."},{"key":"B8","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ejvs.2016.06.005","article-title":"Editor's choice and#x2013; management of descending thoracic aorta diseases: clinical practice guidelines of the european society for vascular surgery (ESVS)","volume":"53","author":"Riambau","year":"2017","journal-title":"Eur J Vasc Endovasc Surg."},{"key":"B9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/joim.12958","article-title":"Lack of an effective drug therapy for abdominal aortic aneurysm","volume":"288","author":"Golledge","year":"2020","journal-title":"J Intern Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1016\/j.jacc.2019.07.063","article-title":"Optimal treatment of uncomplicated type B aortic dissection: JACC review topic of the week","volume":"74","author":"Tadros","year":"2019","journal-title":"J Am Coll Cardiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"NEJM."},{"key":"B12","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: mechanism of assembly, regulation and signalling","volume":"16","author":"Broz","year":"2016","journal-title":"Nat Rev Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"454","DOI":"10.5551\/jat.RV17048","article-title":"Importance of nlrp3 inflammasome in abdominal aortic aneurysms","volume":"28","author":"Shi","year":"2021","journal-title":"J Atheroscler Thromb."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1253\/circj.CJ-21-0258","article-title":"NLRP3 inflammasome as a common denominator of atherosclerosis and abdominal aortic aneurysm","volume":"85","author":"Takahashi","year":"2021","journal-title":"Circ J."},{"key":"B15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1161\/ATVBAHA.114.303763","article-title":"Inflammasome activation by mitochondrial oxidative stress in macrophages leads to the development of angiotensin II-induced aortic aneurysm","volume":"35","author":"Usui","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1161\/CIRCRESAHA.118.311362","article-title":"NLRP3 inflammasome and the IL-1 pathway in atherosclerosis","volume":"122","author":"Grebe","year":"2018","journal-title":"Circ Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s10020-020-00212-z","article-title":"Deficiency in Aim2 affects viability and calcification of vascular smooth muscle cells from murine aortas and angiotensin-II induced aortic aneurysms","volume":"26","author":"Wortmann","year":"2020","journal-title":"Mol Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00011-019-01212-4","article-title":"AIM2 levels and DNA-triggered inflammasome response are increased in peripheral leukocytes of patients with abdominal aortic aneurysm","volume":"68","author":"Wortmann","year":"2019","journal-title":"Inflamm Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"10","author":"Page","year":"2021","journal-title":"Syst Rev."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1093\/cvr\/cvx128","article-title":"Angiotensin II infusion into ApoE-\/- mice: a model for aortic dissection rather than abdominal aortic aneurysm?","volume":"113","author":"Trachet","year":"2017","journal-title":"Cardiovasc Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2288-14-43","article-title":"SYRCLE's risk of bias tool for animal studies","volume":"14","author":"Hooijmans","year":"2014","journal-title":"BMC Med Res Methodol."},{"key":"B22","unstructured":"CAMARADES-Berlin Section 10: Quality Assessment. Preclinical Systematic Reviews and Meta-Analysis Wiki."},{"key":"B23","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1161\/ATVBAHA.116.307648","article-title":"NLRP3 (nucleotide oligomerization domain-like receptor family, pyrin domain containing 3)-caspase-1 inflammasome degrades contractile proteins: implications for aortic biomechanical dysfunction and aneurysm and dissection formation","volume":"37","author":"Wu","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1177\/1074248420919966","article-title":"PKM2 Activator TEPP-46 attenuates thoracic aortic aneurysm and dissection by inhibiting NLRP3 inflammasome-mediated IL-1\u03b2 secretion","volume":"25","author":"Le","year":"2020","journal-title":"J Cardiovasc Pharmacol Ther."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e014044","DOI":"10.1161\/JAHA.119.014044","article-title":"Targeting the NLRP3 inflammasome with inhibitor MCC950 prevents aortic aneurysms and dissections in mice","volume":"9","author":"Ren","year":"2020","journal-title":"J Am Heart Assoc."},{"key":"B26","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.ijcard.2021.05.013","article-title":"H(2)S alleviates aortic aneurysm and dissection: crosstalk between transforming growth factor 1 signaling and NLRP3 inflammasome","volume":"338","author":"Cui","year":"2021","journal-title":"Int J Cardiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1161\/ATVBAHA.117.309575","article-title":"NLRP3 inflammasome inhibition by MCC950 reduces atherosclerotic lesion development in apolipoprotein E-deficient mice-brief report","volume":"37","author":"van der Heijden","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1093\/eurheartj\/ehw247","article-title":"The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction","volume":"38","author":"van Hout","year":"2017","journal-title":"Eur Heart J."},{"key":"B30","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3390\/ph12030118","article-title":"Matrix metalloproteinase in abdominal aortic aneurysm and aortic dissection","volume":"12","author":"Maguire","year":"2019","journal-title":"Pharmaceuticals."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1161\/CIRCULATIONAHA.113.002208","article-title":"Decreased endogenous production of hydrogen sulfide accelerates atherosclerosis","volume":"127","author":"Mani","year":"2013","journal-title":"Circulation."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1016\/j.bbadis.2018.05.023","article-title":"Hydrogen sulfide attenuates oxidative stress-induced NLRP3 inflammasome activation via S-sulfhydrating c-Jun at Cys269 in macrophages","volume":"1864","author":"Lin","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1074\/jbc.M117.806869","article-title":"Hydrogen sulfide inhibits NLRP3 inflammasome activation and reduces cytokine production both in vitro and in a mouse model of inflammation","volume":"293","author":"Castelblanco","year":"2018","journal-title":"J Biol Chem."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1159\/000453208","article-title":"Exogenous hydrogen sulfide attenuates high glucose-induced cardiotoxicity by inhibiting NLRP3 inflammasome activation by suppressing TLR4\/NF-and#x03BA;B pathway in H9c2 Cells","volume":"40","author":"Huang","year":"2016","journal-title":"Cell Physiol Biochem."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1159\/000479405","article-title":"The role of exogenous hydrogen sulfide in free fatty acids induced inflammation in macrophages","volume":"42","author":"Luo","year":"2017","journal-title":"Cell Physiol Biochem."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e005221","DOI":"10.1161\/JAHA.116.005221","article-title":"Transforming growth factor-\u03b2 in thoracic aortic aneurysms: good, bad, or irrelevant?","volume":"6","author":"Daugherty","year":"2017","journal-title":"J Am Heart Assoc."},{"key":"B37","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1083\/jcb.200903124","article-title":"Glyburide inhibits the cryopyrin\/Nalp3 inflammasome","volume":"187","author":"Lamkanfi","year":"2009","journal-title":"J Cell Biol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"4436","DOI":"10.1038\/ncomms5436","article-title":"PKM2 regulates the warburg effect and promotes HMGB1 release in sepsis","volume":"5","author":"Yang","year":"2014","journal-title":"Nat Commun."},{"key":"B39","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cmet.2014.12.005","article-title":"Pyruvate kinase M2 regulates Hif-1\u03b1 activity and IL-1\u03b2 induction and is a critical determinant of the warburg effect in LPS-activated macrophages","volume":"21","author":"Palsson-McDermott","year":"2015","journal-title":"Cell Metab."},{"key":"B40","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jvssci.2021.01.002","article-title":"Translating mouse models of abdominal aortic aneurysm to the translational needs of vascular surgery","volume":"2","author":"Busch","year":"2021","journal-title":"JVS Vasc Sci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1274034","DOI":"10.1155\/2017\/1274034","article-title":"Cardiovascular disease in ageing: an overview on thoracic aortic aneurysm as an emerging inflammatory disease","volume":"2017","author":"Pisano","year":"2017","journal-title":"Mediators Inflamm."},{"key":"B42","doi-asserted-by":"publisher","first-page":"230","DOI":"10.2119\/molmed.2013.00162","article-title":"Increased expression and activation of absent in melanoma 2 inflammasome components in lymphocytic infiltrates of abdominal aortic aneurysms","volume":"20","author":"Dihlmann","year":"2014","journal-title":"Mol Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.3892\/ijmm.2019.4307","article-title":"Inflammasome activity in leucocytes decreases with abdominal aortic aneurysm progression","volume":"44","author":"Erhart","year":"2019","journal-title":"Int J Mol Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1177\/1753944717750338","article-title":"Differential mRNA expression of inflammasome genes NLRP1 and NLRP3 in abdominal aneurysmal and occlusive aortic disease","volume":"12","author":"Gonzalez-Hidalgo","year":"2018","journal-title":"Ther Adv Cardiovasc Dis."},{"key":"B45","doi-asserted-by":"publisher","first-page":"118752","DOI":"10.1016\/j.lfs.2020.118752","article-title":"IFI16 contributes to the pathogenesis of abdominal aortic aneurysm by regulating the caspase-1\/IL-1\u03b2\/MCPIP1 pathway","volume":"265","author":"Xue","year":"2021","journal-title":"Life Sci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"505","DOI":"10.2119\/molmed.2016.00035","article-title":"Sex- and disease-specific inflammasome signatures in circulating blood leukocytes of patients with abdominal aortic aneurysm","volume":"22","author":"Wu","year":"2016","journal-title":"Mol Med."},{"key":"B47","article-title":"Evaluation of AIM2 inflammasome expression in sporadic ascending aortic dissection","author":"Aggedi","year":"","journal-title":"In Proceedings of the 14th Annual Academic Surgical Congress."},{"key":"B48","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3978\/j.issn.2225-319X.2014.07.01","article-title":"Medical management in type B aortic dissection","volume":"3","author":"Suzuki","year":"2014","journal-title":"Ann Cardiothorac Surg."},{"key":"B49","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jvs.2017.10.044","article-title":"The society for vascular surgery practice guidelines on the care of patients with an abdominal aortic aneurysm","volume":"67","author":"Chaikof","year":"2018","journal-title":"J Vasc Surg."},{"key":"B50","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s41232-019-0101-5","article-title":"The role of interleukin-1 in general pathology","volume":"39","author":"Kaneko","year":"2019","journal-title":"Inflamm Regen."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/j.jvs.2012.10.041","article-title":"Interleukin-1\u03b2 pathway antagonism prevents and treats experimental aortic aneurysms","volume":"56","author":"Johnston","year":"2012","journal-title":"J Vasc Surg."},{"key":"B52","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.immuni.2017.10.016","article-title":"Targeting interleukin-1\u03b2 protects from aortic aneurysms induced by disrupted transforming growth factor \u03b2 signaling","volume":"47","author":"Da Ros","year":"2017","journal-title":"Immunity."},{"key":"B53","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jvs.2004.05.020","article-title":"Rapamycin suppresses experimental aortic aneurysm growth","volume":"40","author":"Lawrence","year":"2004","journal-title":"J Vasc Surg."},{"key":"B54","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1161\/01.CIR.0000105725.61763.A2","article-title":"Inhibition of experimental abdominal aortic aneurysm in the rat by use of decoy oligodeoxynucleotides suppressing activity of nuclear factor kappaB and ets transcription factors","volume":"109","author":"Nakashima","year":"2004","journal-title":"Circulation."},{"key":"B55","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.jvs.2004.12.030","article-title":"Suppression of experimental abdominal aortic aneurysms in mice by treatment with pyrrolidine dithiocarbamate, an antioxidant inhibitor of nuclear factor-kappaB","volume":"41","author":"Parodi","year":"2005","journal-title":"J Vasc Surg."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1161\/ATVBAHA.117.309863","article-title":"Deletion of NF-\u03baB\/RelA in Angiotensin II-Sensitive Mesenchymal Cells Blocks Aortic Vascular Inflammation and Abdominal Aortic Aneurysm Formation","volume":"37","author":"Ijaz","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.bbrc.2019.02.051","article-title":"Necrotic cell debris induces a NF-\u03baB-driven inflammasome response in vascular smooth muscle cells derived from abdominal aortic aneurysms (AAA-SMC)","volume":"511","author":"Wortmann","year":"2019","journal-title":"Biochem Biophys Res Commun."},{"key":"B58","doi-asserted-by":"publisher","first-page":"a000034","DOI":"10.1101\/cshperspect.a000034","article-title":"The NF-kappaB family of transcription factors and its regulation","volume":"1","author":"Oeckinghaus","year":"2009","journal-title":"Cold Spring Harb Perspect Biol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1161\/ATVBAHA.121.315942","article-title":"Systematic review and meta-analysis of interventions to slow progression of abdominal aortic aneurysm in mouse models","volume":"41","author":"Phie","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14656566.2021.1999413","article-title":"The role of sulfonylureas in the treatment of type 2 diabetes","author":"Tomlinson","year":"2021","journal-title":"Expert Opin Pharmacother."},{"key":"B61","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3390\/biom10020323","article-title":"Hydrogen sulfide in pharmacotherapy, beyond the hydrogen sulfide-donors","volume":"10","author":"Zaorska","year":"2020","journal-title":"Biomolecules."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.805150\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T01:45:18Z","timestamp":1642643118000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.805150\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,20]]},"references-count":61,"alternative-id":["10.3389\/fcvm.2021.805150"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2021.805150","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,20]]},"article-number":"805150"}}